Small molecules remain on target for c-Myc.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 28100396.
- Also identified by DOI 10.7554/eLife.22915 and PMC identifier 5245958.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Targeting the transcription factor c-Myc via one of its coactivator proteins is a promising strategy for cancer therapy.
Medical subject headings
- Azepines
- Hematologic Neoplasms
- Nuclear Proteins
- Proto-Oncogene Proteins c-myc
- Transcription Factors
- Triazoles